{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:57:05Z","timestamp":1770832625632,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/MED-QUI\/29780\/2017"],"award-info":[{"award-number":["PTDC\/MED-QUI\/29780\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-016585"],"award-info":[{"award-number":["POCI-01-0145-FEDER-016585"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/BBB-EBI\/0567\/2014"],"award-info":[{"award-number":["PTDC\/BBB-EBI\/0567\/2014"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["NORTE-01-0145-FEDER-000029"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-000029"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/136736\/2018"],"award-info":[{"award-number":["SFRH\/BD\/136736\/2018"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PD\/BD\/128407\/2017"],"award-info":[{"award-number":["PD\/BD\/128407\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["Marie Sklodowska-Curie grant agreement n.\u00ba 748880"],"award-info":[{"award-number":["Marie Sklodowska-Curie grant agreement n.\u00ba 748880"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-007274"],"award-info":[{"award-number":["POCI-01-0145-FEDER-007274"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["POCI-01-0145-FEDER-029780"],"award-info":[{"award-number":["POCI-01-0145-FEDER-029780"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s13402-021-00606-z","type":"journal-article","created":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T08:03:44Z","timestamp":1618301024000},"page":"835-850","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Terminal \u03b12,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells"],"prefix":"10.1007","volume":"44","author":[{"given":"Joana G.","family":"Rodrigues","sequence":"first","affiliation":[]},{"given":"Henrique O.","family":"Duarte","sequence":"additional","affiliation":[]},{"given":"Catarina","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"Meritxell","family":"Balma\u00f1a","sequence":"additional","affiliation":[]},{"given":"\u00c1lvaro M.","family":"Martins","sequence":"additional","affiliation":[]},{"given":"Paul J.","family":"Hensbergen","sequence":"additional","affiliation":[]},{"given":"Arnoud H.","family":"de Ru","sequence":"additional","affiliation":[]},{"given":"Jorge","family":"Lima","sequence":"additional","affiliation":[]},{"given":"Andr\u00e9","family":"Albergaria","sequence":"additional","affiliation":[]},{"given":"Peter A.","family":"van Veelen","sequence":"additional","affiliation":[]},{"given":"Manfred","family":"Wuhrer","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Gomes","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0286-6639","authenticated-orcid":false,"given":"Celso A.","family":"Reis","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,4,13]]},"reference":[{"key":"606_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"F. Bray, J. Ferlay, I. Soerjomataram, R.L. Siegel, L.A. Torre, A. Jemal, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J. Clin. 68, 394\u2013424 (2018)","journal-title":"Cancer J. Clin."},{"key":"606_CR2","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","volume":"27","author":"E Van Cutsem","year":"2016","unstructured":"E. Van Cutsem, A. Cervantes, R. Adam, A. Sobrero, J.H. Van Krieken, D. Aderka, E. Aranda Aguilar, A. Bardelli, A. Benson, G. Bodoky, F. Ciardiello, A. D\u2019Hoore, E. Diaz-Rubio, J.Y. Douillard, M. Ducreux, A. Falcone, A. Grothey, T. Gruenberger, K. Haustermans, V. Heinemann, P. Hoff, C.H. K\u00f6hne, R. Labianca, P. Laurent-Puig, B. Ma, T. Maughan, K. Muro, N. Normanno, P. \u00d6sterlund, W.J.G. Oyen, D. Papamichael, G. Pentheroudakis, P. Pfeiffer, T.J. Price, C. Punt, J. Ricke, A. Roth, R. Salazar, W. Scheithauer, H.J. Schmoll, J. Tabernero, J. Ta\u00efeb, S. Tejpar, H. Wasan, T. Yoshino, A. Zaanan, D. Arnold, ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann. Oncol. 27, 1386\u20131422 (2016)","journal-title":"Ann. Oncol."},{"key":"606_CR3","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1056\/NEJMoa071834","volume":"357","author":"DJ Jonker","year":"2007","unstructured":"D.J. Jonker, C.J. O\u2019Callaghan, C.S. Karapetis, J.R. Zalcberg, D. Tu, H.-J. Au, S.R. Berry, M. Krahn, T. Price, R.J. Simes, N.C. Tebbutt, G. van Hazel, R. Wierzbicki, C. Langer, M.J. Moore, Cetuximab for the treatment of colorectal cancer. N. Engl. J. Med. 357, 2040\u20132048 (2007)","journal-title":"N. Engl. J. Med."},{"key":"606_CR4","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1200\/JCO.2006.08.1620","volume":"25","author":"EV Cutsem","year":"2007","unstructured":"E.V. Cutsem, M. Peeters, S. Siena, Y. Humblet, A. Hendlisz, B. Neyns, J.-L. Canon, J.-L.V. Laethem, J. Maurel, G. Richardson, M. Wolf, R.G. Amado, Open-label phase iii trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer. J. Clin. Oncol. 25, 1658\u20131664 (2007)","journal-title":"J. Clin. Oncol."},{"key":"606_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ccr.2005.03.003","volume":"7","author":"S Li","year":"2005","unstructured":"S. Li, K.R. Schmitz, P.D. Jeffrey, J.J.W. Wiltzius, P. Kussie, K.M. Ferguson, Structural basis for inhibition of the epidermal growth factor receptor by cetuximab. Cancer Cell 7, 301\u2013311 (2005)","journal-title":"Cancer Cell"},{"key":"606_CR6","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1056\/NEJMoa0804385","volume":"359","author":"CS Karapetis","year":"2008","unstructured":"C.S. Karapetis, S. Khambata-Ford, D.J. Jonker, C.J. O\u2019Callaghan, D. Tu, N.C. Tebbutt, R.J. Simes, H. Chalchal, J.D. Shapiro, S. Robitaille, T.J. Price, L. Shepherd, H.-J. Au, C. Langer, M.J. Moore, J.R. Zalcberg, K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N. Engl. J. Med. 359, 1757\u20131765 (2008)","journal-title":"N. Engl. J. Med."},{"key":"606_CR7","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1200\/JCO.2007.14.7116","volume":"26","author":"RG Amado","year":"2008","unstructured":"R.G. Amado, M. Wolf, M. Peeters, E.V. Cutsem, S. Siena, D.J. Freeman, T. Juan, R. Sikorski, S. Suggs, R. Radinsky, S.D. Patterson, D.D. Chang, Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J. Clin. Oncol. 26, 1626\u20131634 (2008)","journal-title":"J. Clin. Oncol."},{"key":"606_CR8","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1200\/JCO.2009.24.6116","volume":"28","author":"A Bardelli","year":"2010","unstructured":"A. Bardelli, S. Siena, Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer. J. Clin. Oncol. 28, 1254\u20131261 (2010)","journal-title":"J. Clin. Oncol."},{"key":"606_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/glycob\/cww086","volume":"27","author":"A Varki","year":"2017","unstructured":"A. Varki, Biological roles of glycans. Glycobiology 27, 3\u201349 (2017)","journal-title":"Glycobiology"},{"key":"606_CR10","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3982","volume":"15","author":"SS Pinho","year":"2015","unstructured":"S.S. Pinho, C.A. Reis, Glycosylation in cancer: mechanisms and clinical implications. Nat. Rev. Cancer 15, 540\u2013555 (2015)","journal-title":"Nat. Rev. Cancer"},{"key":"606_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ccell.2019.06.006","volume":"36","author":"S Mereiter","year":"2019","unstructured":"S. Mereiter, M. Balma\u00f1a, D. Campos, J. Gomes, C.A. Reis, Glycosylation in the era of cancer-targeted therapy: where are we heading? Cancer Cell 36, 6\u201316 (2019)","journal-title":"Cancer Cell"},{"key":"606_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/bs.acr.2014.11.004","volume":"126","author":"S Holst","year":"2015","unstructured":"S. Holst, M. Wuhrer, Y. Rombouts, Glycosylation characteristics of colorectal cancer. Adv. Cancer Res. 126, 203\u2013256 (2015)","journal-title":"Adv. Cancer Res."},{"key":"606_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.biocel.2009.09.010","volume":"42","author":"AS Carvalho","year":"2010","unstructured":"A.S. Carvalho, A. Harduin-Lepers, A. Magalh\u00e3es, E. Machado, N. Mendes, L.T. Costa, R. Matthiesen, R. Almeida, J. Costa, C.A. Reis, Differential expression of \u03b1-2,3-sialyltransferases and \u03b1-1,3\/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells. Int. J. Biochem. Cell Biol. 42, 80\u201389 (2010)","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"606_CR14","doi-asserted-by":"crossref","unstructured":"N.T. Marcos, E.P. Bennett, J. Gomes, A. Magalhae, C. Gomes, L. David, I. Dar, C. Jeanneau, S. DeFrees, D. Krustrup, L.K. Vogel, E.H. Kure, J. Burchell, J. Taylor-Papadimitriou, H. Clausen, U. Mandel, C.A. Reis, ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues. Front. Biosci. 3, 1443-1455 (2011)","DOI":"10.2741\/345"},{"key":"606_CR15","doi-asserted-by":"crossref","unstructured":"F. Dall\u2019Olio, N. Malagolini, M. Trinchera, M. Chiricolo, Sialosignaling: Sialyltransferases as engines of self-fueling loops in cancer progression. BBA. Gen. Subj. 1840, 2752\u20132764 (2014)","DOI":"10.1016\/j.bbagen.2014.06.006"},{"key":"606_CR16","doi-asserted-by":"publisher","first-page":"17735","DOI":"10.1016\/S0021-9258(18)45441-5","volume":"262","author":"J Weinstein","year":"1987","unstructured":"J. Weinstein, E.U. Lee, K. McEntee, P.H. Lai, J.C. Paulson, Primary structure of beta-galactoside alpha 2,6-sialyltransferase. Conversion of membrane-bound enzyme to soluble forms by cleavage of the NH2-terminal signal anchor. J. Biol. Chem. 262, 17735\u201317743 (1987)","journal-title":"J. Biol. Chem."},{"key":"606_CR17","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1023\/A:1011077000164","volume":"17","author":"F Dall\u2019Olio","year":"2000","unstructured":"F. Dall\u2019Olio, The sialyl-\u03b12,6-lactosaminyl-structure: Biosynthesis and functional role. Glycoconj. J. 17, 669\u2013676 (2000)","journal-title":"Glycoconj. J."},{"key":"606_CR18","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.bbrc.2017.03.167","volume":"486","author":"S Zhang","year":"2017","unstructured":"S. Zhang, J. Lu, Z. Xu, X. Zou, X. Sun, Y. Xu, A. Shan, J. Lu, X. Yan, Y. Cui, W. Yan, Y. Du, J. Gu, M. Zheng, B. Feng, Y. Zhang, Differential expression of ST6GAL1 in the tumor progression of colorectal cancer. Biochem. Biophys. Res. Commun. 486, 1090\u20131096 (2017)","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"606_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0304-3835(93)90056-F","volume":"75","author":"P Ge\u00dfner","year":"1993","unstructured":"P. Ge\u00dfner, S. Riedl, A. Quentmaier, W. Kemmner, Enhanced activity of CMP-NeuAc:Gal\u03b21-4GlcNAc:\u03b12,6-sialyltransferase in metastasizing human colorectal tumor tissue and serum of tumor patients. Cancer Lett. 75, 143\u2013149 (1993)","journal-title":"Cancer Lett."},{"key":"606_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/1471-2407-9-431","volume":"9","author":"C Costa-Nogueira","year":"2009","unstructured":"C. Costa-Nogueira, S. Villar-Portela, E. Cuevas, E. Gil-Mart\u00edn, Fern\u00e1ndez-Briera, Synthesis and expression of CDw75 antigen in human colorectal cancer. BMC Cancer 9, 431 (2009)","journal-title":"BMC Cancer"},{"key":"606_CR21","doi-asserted-by":"publisher","first-page":"629","DOI":"10.5009\/gnl.2013.7.6.629","volume":"7","author":"J-J Park","year":"2013","unstructured":"J.-J. Park, M. Lee, Increasing the \u03b1 2,6 sialylation of glycoproteins may contribute to metastatic spread and therapeutic resistance in colorectal cancer. Gut Liver 7, 629\u2013641 (2013)","journal-title":"Gut Liver"},{"key":"606_CR22","doi-asserted-by":"publisher","first-page":"34627","DOI":"10.1074\/jbc.M114.593392","volume":"289","author":"J Lu","year":"2014","unstructured":"J. Lu, T. Isaji, S. Im, T. Fukuda, N. Hashii, D. Takakura, N. Kawasaki, J. Gu, \u03b2-Galactoside \u03b12,6-sialyltranferase 1 promotes transforming growth factor-\u03b2-mediated epithelial-mesenchymal transition. J. Biol. Chem. 289, 34627\u201334641 (2014)","journal-title":"J. Biol. Chem."},{"key":"606_CR23","doi-asserted-by":"crossref","unstructured":"C.M. Britain, N. Bhalerao, A.D. Silva, A. Chakraborty, D.J. Buchsbaum, M.R. Crowley, D.K. Crossman, Y.J.K. Edwards, S.L. Bellis, Glycosyltransferase ST6Gal-I promotes the epithelial to mesenchymal transition in pancreatic cancer cells. J. Biol. Chem. 296,\u00a0100034 (2020)","DOI":"10.1074\/jbc.RA120.014126"},{"key":"606_CR24","doi-asserted-by":"publisher","first-page":"5935","DOI":"10.1074\/jbc.R110.191429","volume":"286","author":"Y Zhuo","year":"2011","unstructured":"Y. Zhuo, S.L. Bellis, Emerging role of \u03b12,6-sialic acid as a negative regulator of galectin binding and function. J. Biol. Chem. 286, 5935\u20135941 (2011)","journal-title":"J. Biol. Chem."},{"key":"606_CR25","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.cell.2014.01.043","volume":"156","author":"DO Croci","year":"2014","unstructured":"D.O. Croci, J.P. Cerliani, T. Dalotto-Moreno, S.P. M\u00e9ndez-Huergo, I.D. Mascanfroni, S. Dergan-Dylon, M.A. Toscano, J.J. Caramelo, J.J. Garc\u00eda-Vallejo, J. Ouyang, E.A. Mesri, M.R. Junttila, C. Bais, M.A. Shipp, M. Salatino, G.A. Rabinovich, Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors. Cell 156, 744\u2013758 (2014)","journal-title":"Cell"},{"key":"606_CR26","doi-asserted-by":"publisher","first-page":"5478","DOI":"10.1021\/bi027101p","volume":"42","author":"Y Zhen","year":"2003","unstructured":"Y. Zhen, R.M. Caprioli, J.V. Staros, Characterization of glycosylation sites of the epidermal growth factor receptor. Biochemistry 42, 5478\u20135492 (2003)","journal-title":"Biochemistry"},{"key":"606_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/oxfordjournals.jbchem.a022585","volume":"127","author":"C Sato","year":"2000","unstructured":"C. Sato, J.-H. Kim, Y. Abe, K. Saito, S. Yokoyama, D. Kohda, Characterization of the N-oligosaccharides attached to the atypical Asn-X-Cys sequence of recombinant human epidermal growth factor receptor. J. Biochem. 127, 65\u201372 (2000)","journal-title":"J. Biochem."},{"key":"606_CR28","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/glycob\/cwp023","volume":"19","author":"H-B Guo","year":"2009","unstructured":"H.-B. Guo, H. Johnson, M. Randolph, I. Lee, M. Pierce, Knockdown of GnT-Va expression inhibits ligand-induced downregulation of the epidermal growth factor receptor and intracellular signaling by inhibiting receptor endocytosis. Glycobiology 19, 547\u2013559 (2009)","journal-title":"Glycobiology"},{"key":"606_CR29","doi-asserted-by":"publisher","first-page":"11956","DOI":"10.1074\/jbc.M008551200","volume":"276","author":"Y Sato","year":"2001","unstructured":"Y. Sato, M. Takahashi, Y. Shibukawa, S.K. Jain, R. Hamaoka, J. Miyagawa, Y. Yaginuma, K. Honke, M. Ishikawa, N. Taniguchi, Overexpression of N-acetylglucosaminyltransferase III enhances the epidermal growth factor-induced phosphorylation of ERK in HeLaS3 cells by up-regulation of the internalization rate of the receptors. J. Biol. Chem. 276, 11956\u201311962 (2001)","journal-title":"J. Biol. Chem."},{"key":"606_CR30","doi-asserted-by":"crossref","unstructured":"Y.-C. Liu, H.-Y. Yen, C.-Y. Chen, C.-H. Chen, P.-F. Cheng, Y.-H. Juan, C.-H. Chen, K.-H. Khoo, C.-J. Yu, P.-C. Yang, T.-L. Hsu, C.-H. Wong, Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells. Proc. Natl. Acad. Sci. U. S. A. 108, 11332\u201311337 (2011)","DOI":"10.1073\/pnas.1107385108"},{"key":"606_CR31","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.bcp.2012.01.007","volume":"83","author":"J-J Park","year":"2012","unstructured":"J.-J. Park, J.Y. Yi, Y.B. Jin, Y.-J. Lee, J.-S. Lee, Y.-S. Lee, Y.-G. Ko, M. Lee, Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells. Biochem. Pharmacol. 83, 849\u2013857 (2012)","journal-title":"Biochem. Pharmacol."},{"key":"606_CR32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/glycob\/cwx101","volume":"28","author":"Y Narimatsu","year":"2018","unstructured":"Y. Narimatsu, H.J. Joshi, Z. Yang, C. Gomes, Y.-H. Chen, F.C. Lorenzetti, S. Furukawa, K.T. Schjoldager, L. Hansen, H. Clausen, E.P. Bennett, H.H. Wandall, A validated gRNA library for CRISPR\/Cas9 targeting of the human glycosyltransferase genome. Glycobiology 28, 295\u2013305 (2018)","journal-title":"Glycobiology"},{"key":"606_CR33","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1093\/nar\/gku936","volume":"42","author":"EK Brinkman","year":"2014","unstructured":"E.K. Brinkman, T. Chen, M. Amendola, B. van Steensel, Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 42, e168 (2014)","journal-title":"Nucleic Acids Res."},{"key":"606_CR34","doi-asserted-by":"crossref","unstructured":"M. Bern, Y.J. Kil, C. Becker, Byonic: advanced peptide and protein identification software. Curr. Protoc. Bioinformatics. 40, 13.20.11\u201313.20.14 (2012)","DOI":"10.1002\/0471250953.bi1320s40"},{"key":"606_CR35","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1038\/oncsis.2013.35","volume":"2","author":"D Ahmed","year":"2013","unstructured":"D. Ahmed, P.W. Eide, I.A. Eilertsen, S.A. Danielsen, M. Ekn\u00e6s, M. Hektoen, G.E. Lind, R.A. Lothe, Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis 2, e71 (2013)","journal-title":"Oncogenesis"},{"key":"606_CR36","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1158\/0008-5472.CAN-07-6389","volume":"68","author":"JN Contessa","year":"2008","unstructured":"J.N. Contessa, M.S. Bhojani, H.H. Freeze, A. Rehemtulla, T.S. Lawrence, Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells. Cancer Res. 68, 3803\u20133809 (2008)","journal-title":"Cancer Res."},{"key":"606_CR37","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1074\/mcp.M115.051235","volume":"15","author":"S Holst","year":"2016","unstructured":"S. Holst, A.J.M. Deuss, G.W. van Pelt, S.J. van Vliet, J.J. Garcia-Vallejo, C.A.M. Koeleman, A.M. Deelder, W.E. Mesker, R.A. Tollenaar, Y. Rombouts, M. Wuhrer, N-glycosylation profiling of colorectal cancer cell lines reveals association of Fucosylation with differentiation and caudal type Homebox 1 (CDX1)\/Villin mRNA expression. Mol. Cell. Proteomics 15, 124\u2013140 (2016)","journal-title":"Mol. Cell. Proteomics"},{"key":"606_CR38","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.18632\/oncotarget.22377","volume":"9","author":"N Very","year":"2017","unstructured":"N. Very, T. Lefebvre, I.El Yazidi-Belkoura, Drug resistance related to aberrant glycosylation in colorectal cancer. Oncotarget 9, 1380\u20131402 (2017)","journal-title":"Oncotarget"},{"key":"606_CR39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cellimm.2018.03.007","volume":"333","author":"JG Rodrigues","year":"2018","unstructured":"J.G. Rodrigues, M. Balma\u00f1a, J.A. Macedo, J. Po\u00e7as, \u00c2 Fernandes, J.C.M. de-Freitas-Junior, S.S. Pinho, J. Gomes, A. Magalh\u00e3es, C. Gomes, S. Mereiter, C.A. Reis, Glycosylation in cancer: Selected roles in tumour progression, immune modulation and metastasis. Cell. Immunol. 333, 46\u201357 (2018)","journal-title":"Cell. Immunol."},{"key":"606_CR40","doi-asserted-by":"crossref","unstructured":"K. Kaszuba, M. Grzybek, A. Or\u0142owski, R. Danne, T. R\u00f3g, K. Simons, \u00dc Coskun, I. Vattulainen, N-Glycosylation as determinant of epidermal growth factor receptor conformation in membranes. Proc. Natl. Acad. Sci. U. S. A. 112, 4334\u20134339 (2015)","DOI":"10.1073\/pnas.1503262112"},{"key":"606_CR41","doi-asserted-by":"publisher","first-page":"7509","DOI":"10.3390\/molecules20057509","volume":"20","author":"J Lu","year":"2015","unstructured":"J. Lu, J. Gu, Significance of \u03b2-galactoside \u03b12,6 sialyltranferase 1 in cancers. Molecules 20, 7509\u20137527 (2015)","journal-title":"Molecules"},{"key":"606_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1757-2215-6-25","volume":"6","author":"MJ Schultz","year":"2013","unstructured":"M.J. Schultz, A.F. Swindall, J.W. Wright, E.S. Sztul, C.N. Landen, S.L. Bellis, ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells. J. Ovarian Res. 6, 25 (2013)","journal-title":"J. Ovarian Res."},{"key":"606_CR43","doi-asserted-by":"crossref","unstructured":"P.R. Punch, E.E. Irons, C.T. Manhardt, H. Marathe, J.T.Y. Lau, The sialyltransferase ST6GAL1 protects against radiation-induced gastrointestinal damage. Glycobiology 30, 446-453 (2020)","DOI":"10.1093\/glycob\/cwz108"},{"key":"606_CR44","doi-asserted-by":"publisher","first-page":"4663","DOI":"10.1074\/jbc.M116.763862","volume":"292","author":"CM Britain","year":"2017","unstructured":"C.M. Britain, K.A. Dorsett, S.L. Bellis, The glycosyltransferase ST6Gal-I protects tumor cells against serum growth factor withdrawal by enhancing survival signaling and proliferative potential. J. Biol. Chem. 292, 4663\u20134673 (2017)","journal-title":"J. Biol. Chem."},{"key":"606_CR45","doi-asserted-by":"publisher","first-page":"5659","DOI":"10.1074\/jbc.RA117.001194","volume":"293","author":"RB Jones","year":"2018","unstructured":"R.B. Jones, K.A. Dorsett, A.B. Hjelmeland, S.L. Bellis, The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1\u03b1 signaling. J. Biol. Chem. 293, 5659\u20135667 (2018)","journal-title":"J. Biol. Chem."},{"key":"606_CR46","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1158\/0008-5472.CAN-15-2834","volume":"76","author":"MJ Schultz","year":"2016","unstructured":"M.J. Schultz, A.T. Holdbrooks, A. Chakraborty, W.E. Grizzle, C.N. Landen, D.J. Buchsbaum, M.G. Conner, R.C. Arend, K.J. Yoon, C.A. Klug, D.C. Bullard, R.A. Kesterson, P.G. Oliver, A.K. O\u2019Connor, B.K. Yoder, S.L. Bellis, The tumor-associated glycosyltransferase ST6Gal-I regulates stem cell transcription factors and confers a cancer stem cell phenotype. Cancer Res. 76, 3978\u20133988 (2016)","journal-title":"Cancer Res."},{"key":"606_CR47","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1158\/0008-5472.CAN-12-3424","volume":"73","author":"AF Swindall","year":"2013","unstructured":"A.F. Swindall, A.I. Londo\u00f1o-Joshi, M.J. Schultz, N. Fineberg, D.J. Buchsbaum, S.L. Bellis, ST6Gal-I protein expression is upregulated in human epithelial tumors and correlates with stem cell markers in normal tissues and colon cancer cell lines. Cancer Res. 73, 2368\u20132378 (2013)","journal-title":"Cancer Res."},{"key":"606_CR48","doi-asserted-by":"publisher","first-page":"4645","DOI":"10.1158\/0008-5472.CAN-04-3117","volume":"65","author":"EC Seales","year":"2005","unstructured":"E.C. Seales, G.A. Jurado, B.A. Brunson, J.K. Wakefield, A.R. Frost, S.L. Bellis, Hypersialylation of \u03b21 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Res. 65, 4645\u20134652 (2005)","journal-title":"Cancer Res."},{"key":"606_CR49","doi-asserted-by":"publisher","first-page":"22982","DOI":"10.1074\/jbc.M110.211375","volume":"286","author":"AF Swindall","year":"2011","unstructured":"A.F. Swindall, S.L. Bellis, Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells. J. Biol. Chem. 286, 22982\u201322990 (2011)","journal-title":"J. Biol. Chem."},{"key":"606_CR50","doi-asserted-by":"crossref","unstructured":"Q. Zhang, J.N. Higginbotham, D.K. Jeppesen, Y.-P. Yang, W. Li, E.T. McKinley, R. Graves-Deal, J. Ping, C.M. Britain, K.A. Dorsett, C.L. Hartman, D.A. Ford, R.M. Allen, K.C. Vickers, Q. Liu, J.L. Franklin, S.L. Bellis, R.J. Coffey, Transfer of functional cargo in exomeres. Cell Rep. 27, 940-954.e6 (2019)","DOI":"10.1016\/j.celrep.2019.01.009"},{"key":"606_CR51","doi-asserted-by":"crossref","unstructured":"H. Zhang, D. Freitas, H.S. Kim, K. Fabijanic, Z. Li, H. Chen, M.T. Mark, H. Molina, A.B. Martin, L. Bojmar, J. Fang, S. Rampersaud, A. Hoshino, I. Matei, C.M. Kenific, M. Nakajima, A.P. Mutvei, P. Sansone, W. Buehring, H. Wang, J.P. Jimenez, L. Cohen-Gould, N. Paknejad, M. Brendel, K. Manova-Todorova, A. Magalh\u00e3es, J.A. Ferreira, H. Os\u00f3rio, A.M. Silva, A. Massey, J.R. Cubillos-Ruiz, G. Galletti, P. Giannakakou, A.M. Cuervo, J. Blenis, R. Schwartz, M.S. Brady, H. Peinado, J. Bromberg, H. Matsui, C.A. Reis, D. Lyden, Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat. Cell Biol. 20, 332\u2013343 (2018)","DOI":"10.1038\/s41556-018-0040-4"},{"key":"606_CR52","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1002\/jcp.22570","volume":"226","author":"ME Irwin","year":"2011","unstructured":"M.E. Irwin, K.L. Mueller, N. Bohin, Y. Ge, J.L. Boerner, Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib. J. Cell. Physiol. 226, 2316\u20132328 (2011)","journal-title":"J. Cell. Physiol."},{"key":"606_CR53","doi-asserted-by":"publisher","first-page":"66491","DOI":"10.18632\/oncotarget.11582","volume":"7","author":"MP Mathew","year":"2016","unstructured":"M.P. Mathew, E. Tan, C.T. Saeui, P. Bovonratwet, S. Sklar, R. Bhattacharya, K.J. Yarema, Metabolic flux-driven sialylation alters internalization, recycling, and drug sensitivity of the epidermal growth factor receptor (EGFR) in SW1990 pancreatic cancer cells. Oncotarget 7, 66491\u201366511 (2016)","journal-title":"Oncotarget"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-021-00606-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-021-00606-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-021-00606-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T12:24:37Z","timestamp":1628079877000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-021-00606-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,13]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["606"],"URL":"https:\/\/doi.org\/10.1007\/s13402-021-00606-z","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,13]]},"assertion":[{"value":"8 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.\u00a0","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.\u00a0","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.\u00a0","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}